GAM
EXAS

Gotham Asset Management’s Exact Sciences EXAS Stock Holding History

Gotham Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-74,464
Closed -$7.56M – 1786
2025
Q4 		$7.56M Buy
74,464
+63,034
+551% +$5.06M 0.03% 723
2025
Q3 		$625K Sell
11,430
-97,510
-90% -$4.87M ﹤0.01% 1335
2025
Q2 		$5.79M Buy
108,940
+32,361
+42% +$1.64M 0.03% 622
2025
Q1 		$3.32M Sell
76,579
-73,541
-49% -$3.72M 0.03% 645
2024
Q4 		$8.44M Sell
150,120
-12,302
-8% -$766K 0.08% 358
2024
Q3 		$11.1M Buy
162,422
+30,873
+23% +$1.74M 0.11% 250
2024
Q2 		$5.56M Buy
131,549
+56,440
+75% +$3.11M 0.07% 398
2024
Q1 		$5.19M Buy
75,109
+8,650
+13% +$547K 0.08% 351
2023
Q4 		$4.92M Sell
66,459
-27,822
-30% -$1.82M 0.09% 303
2023
Q3 		$6.43M Buy
94,281
+4,347
+5% +$369K 0.13% 171
2023
Q2 		$8.44M Buy
89,934
+11,100
+14% +$866K 0.18% 97
2023
Q1 		$5.35M Sell
78,834
-2,086
-3% -$134K 0.13% 174
2022
Q4 		$4.01M Buy
80,920
+46,059
+132% +$1.88M 0.11% 219
2022
Q3 		$1.13M Buy
+34,861
New +$1.44M 0.03% 612
2022
Q2 		– Sell
-6,092
Closed -$426K – 1159
2022
Q1 		$426K Sell
6,092
-2,398
-28% -$175K 0.01% 850
2021
Q4 		$661K Buy
8,490
+1,815
+27% +$160K 0.02% 671
2021
Q3 		$637K Buy
6,675
+1,940
+41% +$205K 0.03% 597
2021
Q2 		$589K Buy
4,735
+33
+0.7% +$3.94K 0.03% 644
2021
Q1 		$620K Sell
4,702
-1,134
-19% -$155K 0.03% 624
2020
Q4 		$773K Sell
5,836
-1,027
-15% -$124K 0.03% 609
2020
Q3 		$700K Sell
6,863
-1,250
-15% -$108K 0.02% 650
2020
Q2 		$705K Buy
8,113
+9
+0.1% +$719 0.02% 662
2020
Q1 		$470K Buy
8,104
+2,099
+35% +$170K 0.01% 732
2019
Q4 		$555K Buy
+6,005
New +$528K 0.01% 779
2019
Q3 		– Sell
-3,591
Closed -$424K – 1124
2019
Q2 		$424K Sell
3,591
-41,400
-92% -$4.17M 0.01% 850
2019
Q1 		$3.9M Buy
44,991
+944
+2% +$80.4K 0.06% 385
2018
Q4 		$2.78M Buy
44,047
+221
+0.5% +$15.2K 0.04% 428
2018
Q3 		$3.46M Sell
43,826
-48,316
-52% -$3.15M 0.05% 410
2018
Q2 		$5.51M Sell
92,142
-36,472
-28% -$1.96M 0.08% 322
2018
Q1 		$5.19M Sell
128,614
-86,423
-40% -$4.22M 0.07% 353
2017
Q4 		$11.3M Sell
215,037
-121,882
-36% -$6.51M 0.16% 196
2017
Q3 		$15.9M Buy
336,919
+154,834
+85% +$6.23M 0.23% 130
2017
Q2 		$6.44M Buy
182,085
+126,037
+225% +$3.89M 0.09% 317
2017
Q1 		$1.32M Buy
+56,048
New +$1.11M 0.02% 619
2016
Q4 		– Sell
-53,252
Closed -$989K – 976
2016
Q3 		$989K Buy
53,252
+35,583
+201% +$627K 0.01% 604
2016
Q2 		$216K Buy
+17,669
New +$133K ﹤0.01% 876

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gotham Asset Management's EXAS Position: Q1 2026 in Review

Gotham Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 74,464 shares — an estimated $7.56M sold.

Gotham Asset Management first reported a position in EXAS in Q2 2016 and held it in 36 quarters. The position peaked at $15.9M in Q3 2017. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Gotham Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Gotham Asset Management sold 74,464 Exact Sciences shares in Q1 2026, an estimated $7.56M.
  • Gotham Asset Management first reported a position in Exact Sciences in Q2 2016 and held it in 36 quarters.
  • Gotham Asset Management's Exact Sciences position peaked at $15.9M in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.